Dr. Michael R. Grever M.D.
Hematologist-Oncologist | Hematology & Oncology
300 W 10th Ave Columbus OH, 43210About
Dr. Michael Grever is a hematologist oncologist practicing in Columbus, OH. Dr. Grever specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Pittsburgh Sch of Med, Pittsburgh Pa 1971
University of Pittsburgh School of Medicine 1971
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells.
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
- Pentostatin (Nipent): a review of potential toxicity and its management.
- Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
- Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies.
- Novel therapies for chronic lymphocytic leukemia in the 21st century.
- Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
- Cytotoxic alkaloids from Tylophora indica.
- UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
- Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells.
- Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells.
- KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis.
- Neural computing in cancer drug development: predicting mechanism of action.
- The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells.
- G3139, a BCL-2 antisense oligo-nucleotide, in AML.
Clinical Trials
Treatments
- Leukemia
- Extra Corporeal Shockwave Therapy
Fellowships
- Hematology: Ohio State University Wexner Medical Center 1976
Dr. Michael R. Grever M.D.'s Practice location
Columbus, OH 43210Get Direction
Dr. Michael R. Grever M.D.'s reviews
Write ReviewRecommended Articles
- This New Zealand Native Beat Cancer Eight Times
Being diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
- Lymphoma: The Importance of a Support System & Communication
Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...
- Life Lessons After Multiple Misdiagnoses of Lymphoma
28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Multiple Myeloma: What is Autotransplantation?
During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
Nearby Providers
- Mrs. Sudhathi Chennuru M.D.300 Polaris Pkwy Westerville Ohio 43082
- Dr. Basem William MD500 Thomas Ln Columbus OH 43214
- Dr. Folefac Edmund M.D.460 W 10th Ave Columbus OH 43210
- Dr. Seema Bhat MD460 W 10TH AVE COLUMBUS OH 43210
- Dr. Christopher S George M.D.810 Jasonway Ave Columbus OH 43214
- Dr. Craig C Hofmeister MD300 W 10th Ave Columbus OH 43210